HOME I ABOUT US I CONTACT US
 

A Late Stage Specialty Immune Globulin Company
Focused on Improving the Quality of Care for Immunocompromised Patients

Recent News

ADMA Biologics Commences Pivotal Phase III Clinical Study of RI-002 in PIDD Patients
ADMA Biologics Reports 2012 Year End Financial and Operational Results

Executes Long-Term Manufacturing, Supply and License Agreements with Biotest

 ADMA Biologics Secures Up To $6 Million Term Loan Commitment To Advance Phase III Study

 
© 2012 ADMA Biologics, Inc. All rights reserved. ADMA Biologics, Inc. I 65 Commerce Way, Hackensack, NJ 07601 I Tel: 201.478.5552 I Fax: 201.478.5553